Cueto, Calixto M.

HRN: 14-52-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CIPROFLOXACIN 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
BID
E. Histolytica
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Choice  Specific Therapy For E. Histolytica: Metronidazole 500-750mg PO Tid (NAG)

Final appropriateness: No  Wrong Choice 

Overall appropriateness: No  Follow Recommended Antibiotic By NAG

Intervention



Type of Intervention done:

                    

           


Acceptance: